(NASDAQ: IFRX) Inflarx Nv's forecast annual revenue growth rate of 835.62% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Inflarx Nv's revenue in 2025 is $181,181.On average, 2 Wall Street analysts forecast IFRX's revenue for 2025 to be $90,680,239, with the lowest IFRX revenue forecast at $60,060,937, and the highest IFRX revenue forecast at $121,299,540. On average, 2 Wall Street analysts forecast IFRX's revenue for 2026 to be $2,945,341,265, with the lowest IFRX revenue forecast at $128,954,366, and the highest IFRX revenue forecast at $5,761,728,165.
In 2027, IFRX is forecast to generate $9,912,998,841 in revenue, with the lowest revenue forecast at $9,912,998,841 and the highest revenue forecast at $9,912,998,841.